Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 377

Similar articles for PubMed (Select 17497175)

1.

Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.

Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, Kvale P, Hayes RB, Chanock SJ, Caporaso NE.

Hum Genet. 2007 Aug;122(1):41-9. Epub 2007 May 12.

PMID:
17497175
2.

SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Azzato EM, Morton LM, Bergen AW, Wang SS, Chatterjee N, Kvale P, Yeager M, Hayes RB, Chanock SJ, Caporaso NE.

BMC Med Genet. 2009 Jan 30;10:9. doi: 10.1186/1471-2350-10-9.

3.

Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.

Tanaka Y, Sasaki M, Shiina H, Tokizane T, Deguchi M, Hirata H, Hinoda Y, Okayama N, Suehiro Y, Urakami S, Kawakami T, Kaneuchi M, Pookot D, Igawa M, Okuyama A, Ishii N, Dahiya R.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):238-44.

4.

DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Morton LM, Wang SS, Bergen AW, Chatterjee N, Kvale P, Welch R, Yeager M, Hayes RB, Chanock SJ, Caporaso NE.

Pharmacogenet Genomics. 2006 Dec;16(12):901-10.

PMID:
17108814
5.

The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.

Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M.

Pharmacogenet Genomics. 2008 Sep;18(9):815-21. doi: 10.1097/FPC.0b013e328306c2f2.

PMID:
18698234
6.

Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.

Suzuki K, Nakazato H, Matsui H, Koike H, Okugi H, Kashiwagi B, Nishii M, Ohtake N, Nakata S, Ito K, Yamanaka H.

Cancer. 2003 Oct 1;98(7):1411-6.

7.

Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.

Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, Ahn SH, Noh DY, Choe KJ, Jang IJ, Shin SG, Strickland PT, Hirvonen A, Kang D.

Pharmacogenetics. 2001 Jun;11(4):279-86.

PMID:
11434504
8.

Two single nucleotide polymorphisms in the CYP17 and COMT Genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study.

Tofteng CL, Abrahamsen B, Jensen JE, Petersen S, Teilmann J, Kindmark A, Vestergaard P, Gram J, Langdahl BL, Mosekilde L.

Calcif Tissue Int. 2004 Aug;75(2):123-32. Epub 2004 Apr 29.

PMID:
15129369
9.

Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study.

Kang D, Lee KM, Park SK, Berndt SI, Peters U, Reding D, Chatterjee N, Welch R, Chanock S, Huang WY, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1581-6. Epub 2007 Jul 23.

10.

The effect of catechol-O-methyltransferase Met/Val functional polymorphism on smoking cessation: retrospective and prospective analyses in a cohort study.

Omidvar M, Stolk L, Uitterlinden AG, Hofman A, Van Duijn CM, Tiemeier H.

Pharmacogenet Genomics. 2009 Jan;19(1):45-51.

PMID:
19160592
11.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.

Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I.

Int Clin Psychopharmacol. 2010 Jul;25(4):218-27. doi: 10.1097/YIC.0b013e328338b884.

PMID:
20531207
12.

A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a Danish prospective case-cohort study.

Hansen RD, Sørensen M, Tjønneland A, Overvad K, Wallin H, Raaschou-Nielsen O, Vogel U.

BMC Cancer. 2008 Feb 20;8:54. doi: 10.1186/1471-2407-8-54.

13.

Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.

Sweet RA, Devlin B, Pollock BG, Sukonick DL, Kastango KB, Bacanu SA, Chowdari KV, DeKosky ST, Ferrell RE.

Mol Psychiatry. 2005 Nov;10(11):1026-36.

PMID:
16027741
14.

Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers.

Guo S, Chen da F, Zhou DF, Sun HQ, Wu GY, Haile CN, Kosten TA, Kosten TR, Zhang XY.

Psychopharmacology (Berl). 2007 Mar;190(4):449-56. Epub 2007 Jan 6.

PMID:
17206495
15.

Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.

Goodman JE, Lavigne JA, Hengstler JG, Tanner B, Helzlsouer KJ, Yager JD.

Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1373-6.

16.

Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer.

Garner EI, Stokes EE, Berkowitz RS, Mok SC, Cramer DW.

Cancer Res. 2002 Jun 1;62(11):3058-62.

17.

Sex differences in the influence of COMT Val158Met on alcoholism and smoking in plains American Indians.

Enoch MA, Waheed JF, Harris CR, Albaugh B, Goldman D.

Alcohol Clin Exp Res. 2006 Mar;30(3):399-406.

PMID:
16499480
18.

Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.

Borroni B, Grassi M, Costanzi C, Zanetti M, Archetti S, Franzoni S, Caimi L, Padovani A.

Neurobiol Aging. 2007 Aug;28(8):1231-8. Epub 2006 Jul 11.

PMID:
16837108
19.
20.

Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain.

Rakvåg TT, Ross JR, Sato H, Skorpen F, Kaasa S, Klepstad P.

Mol Pain. 2008 Dec 18;4:64. doi: 10.1186/1744-8069-4-64.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk